If you (or someone you know) has been diagnosed with two or more nonmelanoma skin cancers, you are part of a special group. You are also, unfortunately, at much higher risk of developing further skin cancers. Here’s why — and what you can do about it.
The last thing Summer Sanders expected to hear at a routine visit to her dermatologist was the word “melanoma.” Although the olive-skinned swimmer had grown up training in outdoor pools under the intense California sun, she had never consciously tried to get tan and never considered herself at risk for skin cancer. It just wasn’t on her radar, especially when making it into the Olympics took so much of her focus.
You may have heard about a new medication that was recently FDA approved for cutaneous squamous cell carcinoma (CSCC). Libtayo (cemiplimab-rwlc) is a type of immunotherapy called a checkpoint blockade inhibitor, and it’s the first one approved to treat certain cases of CSCC. This is exciting news, so let’s break down how this new drug works and whom it might help.
Your eyes can focus on a tiny splinter in the finger of a squirming child, a stop sign in the distance or stars blinking light-years away. You can roll your eyes, flirt with them, do a double-take and express joy or despair without words. When you think about how amazing your eyes are, wouldn’t you do anything to protect them?
What happens to your biopsy tissue sample after your dermatologist ships it off to the lab?
Knowing when and what to biopsy is an important skill set for a dermatologist, but getting an accurate diagnosis is still a complicated process. That’s where a dermatopathologist comes in.
The brave men and women who serve our country know they accept some risks, but they may not know that one of them is skin cancer. We asked Jonathan L. Bingham, MD, a Mohs surgeon in Great Falls, Montana, and a flight surgeon with the Montana Air National Guard, to tell us more about this danger.